Industry Watch
•  SLT's Hepatitis A Diagnostic Kits under Licensing Evaluation
•  First Logistics and Delivery Center in Shenzhen Launched
•  China's First Anti-AIDS Intermediates Production Facility
•  Eli Lilly Dispersible Prozac Tablets Available in China
•  Micro Labs Expands Manufacturing Capacities
•  Paradigm Sets up Subsidiary in Singapore
•  TaiGen Receives Funding for Anti-SARS Research
•  Xcyte Therapies Partners Taiwan Cell Therapy in Cancer Technology

Products/Services Highlight
•  CCS� Latest Solutions to Tackle Cold Chain Failure
•  Whatman's FTA Technology
•  Online Gene Expression Data Analysis Service
•  Fernandez & Associates Launches Biotech Practice

Rules & Regulations
•  Good Pharmacy Practice Implementation
•  SFDA's Latest Regulation for Diagnostic Reagents
•  Drugs Covered under Beijing Basic Insurance Scheme

Agriculture
•  Serious Consequences for Boycotting GM Technology
•  SBBPL and NBRI in GM Technology Licensing Agreement
•  Gates Foundation Offers Funding for HarvestPlus Initiative
•  Time to Address IP Protection for GM Technology?

Alternative Medicine
•  Plans for New Herbal Medicine Research Facility
•  Health Concerns over Herbal Beverages� Alcohol Contents
•  Dapumei Herbal Biotechnology Park in Taiwan

General News
•  Indonesia Outlines BioIsland Project
•  Japan's Online Medicine Database
•  Latest Mad Cow Case Confirmed Not Mutated Strain
•  New Funding for Biotech Sector
•  Watershed for Singapore's Biomedical Sciences Sector
•  JDRF's Stem Cell Research Commitment in Asia

Global Development
•  Global Search for SARS Vaccine Gains Momentum

Education
•  First John Hopkins Overseas Education Division

People
•  Tadamitsu Kishimoto

Conference Calendar